Related references
Note: Only part of the references are listed.The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma
Serife Solmaz et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)
Identification and transcriptome analysis of erythroblastic island macrophages
Wei Li et al.
BLOOD (2019)
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes
Abdullah Mahmood Ali et al.
BLOOD ADVANCES (2018)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Isolation and characterization of human mesenchymal stem cells from gingival connective tissue
S. H. Jin et al.
JOURNAL OF PERIODONTAL RESEARCH (2015)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress
Andrew Chow et al.
NATURE MEDICINE (2013)
Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression
Christine Grigorakaki et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Klf1 Affects DNase II-Alpha Expression in the Central Macrophage of a Fetal Liver Erythroblastic Island: a Non-Cell-Autonomous Role in Definitive Erythropoiesis
Susanna Porcu et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients
I. Pavese et al.
ANNALS OF ONCOLOGY (2010)
Lack of the bone morphogenetic protein BMP6 induces massive iron overload
Delphine Meynard et al.
NATURE GENETICS (2009)
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Billy Andriopoulos et al.
NATURE GENETICS (2009)
Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation
Isabelle Buck et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Involvement of hepcidin in the anemia of multiple myeloma
Sanjai Sharma et al.
CLINICAL CANCER RESEARCH (2008)
Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin
Melissa M. Rhodes et al.
BLOOD (2008)
Supportive care in multiple myeloma
Heinz Ludwig et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion
Shivani Soni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hyporesponsiveness to erythropoietic therapy due to chronic inflammation
IC Macdougall et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway
M Chatterjee et al.
BLOOD (2002)
Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells:: a major pathogenetic mechanism of anemia in multiple myeloma
F Silvestris et al.
BLOOD (2002)
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression
F Silvestris et al.
BLOOD (2001)
Share Paper
